Skip to main content
. 2011 Dec 1;6(3):576–590. doi: 10.1007/s12072-011-9324-5

Table 2.

Overview of case series

Authors ([Ref.]) Procedure-related complications Shunt dysfunction Encephalopathy Survival
Luca et al. ([80]) Stent migration into the MPV (1) 1-, 2-year cumulative rate 1-, 2-year cumulative rate TIPS success group:
 38%, 85% for bare stents
 21%, 29% for covered stents  27%, 32%  1-, 2-year cumulative survival rate: 89 and 81%
Han et al. (78) Hepatic capsule perforation (2) 1-, 2-year cumulative rate 1-, 2-year cumulative rate: TIPS success group:
 1 died of intraperitoneal bleeding  1-, 5-year cumulative survival rate: 86%, 77%
 1 was rescued TIPS failure group:
Bile duct puncture (1)  21%, 32% for bare stents. 25%, 27%  1-, 5-year cumulative survival rate: 78%, 62%
Luo et al. ([79]) Intraperitoneal bleeding and death (1) 15% (2/13) 8% (1/13) TIPS success group:
Hematoma beneath the hepatic capsule (reversible) (1)  Survival rate: 92% (12/13)
Fanelli et al. ([77]) Intraperitoneal bleeding (reversible) (1) 30% (3/10) 20% (2/10) TIPS success group:
Survival rate: 70% (7/10).
1 died of sepsis (6.3 months); 1 of ischemic stroke; 1 of neoplasm (9.3 months)
TIPS failure group:
  Survival rate: 100% (3/3)
Perarnau et al. ([76]) Early thrombosis (3) 28% (8/29) 1-, 2-year cumulative rate: 27%, 27% TIPS success group:
Hemobilia (1)  1-, 2-, 4-year cumulative survival rate: 80%, 72%, 55%
Digestive bleeding (1) TIPS failure group: NA
Liu et al. ([72]) No 12% (3/26) 0% (0/26) TIPS success group:
 Survival rate: 96% (25/26)
1 died of abdominal abscess and MOF
Gazzera et al. ([67]) NA NA NA NA
Semiz-Oysu et al. ([66]) NA NA NA TIPS success group:
 Survival rate: 60% (6/10) 1 died of continued bleeding (8 days)
1 of HRS and sepsis (28 days); 1 of intraperitoneal bleeding (3 days); 1 of intractable gastrointestinal bleeding (3 months)
Bauer et al. ([63]) No 11% (1/9) 0% (0/9) TIPS success group:
 Survival rate: 78% (7/9)
1 died of renal failure and sepsis (44 months); 1 of massive variceal bleeding without portal vein recanalization (42 months)
Van Ha et al. ([61]) Hematoma in the neck (1) 8% (1/13) 8% (1/13) TIPS success group: survival rate: 85% (11/13)
2 died of MOF (7, 20 days) TIPS failure group: 1 died of variceal bleeding (12 days); 1 lost to follow-up
Senzolo et al. (56) Capsular perforation without sequelae (10) 32% (6/19) 5% (1/19) TIPS success group:
 Survival rate: 95% (18/19)
1 died of bleeding
TIPS failure group:
Extrahepatic portal vein laceration (cured by covered stent) (1)  Survival rate: 78% (7/9)
Biliary punctures without sequelae (3) 1 died of RVB; 1 died of underlying hematological diseases
Wallace et al. ([55]) NA NA NA NA
Bilbao et al. ([52]) No 50% (3/6) 0% (0/6) TIPS success group:
Survival rate: 83% (5/6)
1 died of tumor progression (10 months)
Jiang et al. ([53]) Needle puncture through the liver and into the peritoneum cavity without sequelae (2) 20% (2/10) 50% (5/10) TIPS success group:
Mean survival time: 132.3 days
5 died of dyscrasia or liver failure
TIPS failure group:
Mean survival time: 34 days
Ganger et al. ([39]) Laceration of liver and capsule (died) (1) 33% (3/9) NA TIPS success group:
 Survival rate: 78% (7/9)
1 died of MOF (0.5 month), 1 died of TIPS complications
Laceration of IVC (reversible) (1) TIPS failure group: NA
Stein et al. ([40]) Minor subcapsular bleeding (1) 2/12 (17%) NA NA
Biliary leak from intrahepatic duct (1)
Walser et al. ([37]) No 9 shunt revisions (up to 5 per patient) NA TIPS success group: NA
TIPS failure group:
 Alive for a mean interval of 14 months
Blum et al. ([31]) No 14% (1/7) 0% (0/7) TIPS success group:
Survival rate: 86% (6/7); 1 died of progressive liver failure with sepsis (1 month)
Radosevich et al. ([28]) No 29% (2/7) 0% (0/7) TIPS success group:
 Survival rate: 71% (5/7)
1 died of hepatoma (1 day), 1 of progressive liver failure (2 months)
TIPS failure group:
 2 alive; 1 lost to follow-up

HRS hepatorenal syndrome, IVC inferior vena cava, MOF multiple organ failure, MPV main portal vein, NA not available, RVB recurrent variceal bleeding, TIPS transjugular intrahepatic portoysystemic shunt